About: John R Perfect

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: John R Perfect Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher (ORCID 0000-0002-8742-3676)

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) 연구원 (ko) 研究者 (ja) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) onderzoeker (nl) researcher (ORCID 0000-0002-8742-3676) (en)
rdfs:label	John R Perfect (en) John R Perfect (es) John R Perfect (nl) John R Perfect (ast)
skos:prefLabel	John R Perfect (en) John R Perfect (es) John R Perfect (nl) John R Perfect (ast)
name	John R Perfect (en) John R Perfect (es) John R Perfect (nl) John R Perfect (ast)
given name	wds:Q64932411-D7E4720F-1481-44BC-9265-42DABA3934EF
given name	John
instance of	wds:Q64932411-63CB78A9-94E3-4106-8E6C-87F64D51FA12
instance of	Homo sapiens
Semantic Scholar author ID	wds:Q64932411-B80B1779-B5B7-4DC0-AFA0-7F2433D179B4
Semantic Scholar author ID	50006926
skos:altLabel	John Perfect (en)
occupation	wds:Q64932411-3A049B27-DB12-4937-A25C-3FB931E77EE6
employer	wds:Q64932411-A9D6772E-C657-4751-A1B1-4C966E9DC334
CiNii Research ID	wds:Q64932411-F34F560C-C1AF-4516-A0BA-06544B1A800B
sex or gender	wds:Q64932411-4DA43613-F56A-4391-8C52-8149FB0AF423
VIAF ID	wds:Q64932411-AF73CE00-49C2-4A33-9F01-A3DED643DAF9
IdRef ID	wds:Q64932411-73E84EF2-5C88-47B8-8437-F5360171888E
NACSIS-CAT author ID	wds:Q64932411-A70C2661-42B3-4A62-887F-490A4B254414
date of birth	wds:Q64932411-EFC78AD6-ECCA-4835-9626-946848D7ABB9
maintained by WikiProject	wds:Q64932411-19D380E9-7388-4818-B8F7-A91575CF1A96
educated at	wds:Q64932411-BEA50390-DD1E-4220-B4D0-ADE3965D26B9 wds:Q64932411-D01CE884-BB8C-4A6D-8052-77884DC77C50
PLWABN ID	wds:Q64932411-EE80FFA7-4D58-442A-ABC6-23A3B1B0A031
family name	wds:Q64932411-6227A069-7452-483B-B41E-691DFAD0BA69
National Library of Israel J9U ID	wds:Q64932411-CCB9BABC-B16E-40FF-BF08-738A4FCF71AA
CiNii Research ID	https://cir.nii.ac.jp/crid/1140563741811369088.rdf
VIAF ID	http://viaf.org/viaf/116604411
IdRef ID	http://www.idref.fr/147060591/id
NACSIS-CAT author ID	https://ci.nii.ac.jp/author/DA12119361#entity
occupation	researcher
employer	Duke University
CiNii Research ID	1140563741811369088
sex or gender	male
VIAF ID	116604411
IdRef ID	147060591
NACSIS-CAT author ID	DA12119361
date of birth	1949-01-01 00:00:00Z (xsd:dateTime)
maintained by WikiProject	WikiProject Invasion Biology
educated at	Mercy College of Northwest Ohio Wittenberg University
PLWABN ID	9810567623005606
family name	Perfect
National Library of Israel J9U ID	987007326004905171
ORCID iD	wds:Q64932411-0AC97A5E-C300-4521-9D7A-99B11C383705
ORCID iD	https://orcid.org/0000-0002-8742-3676
ORCID iD	0000-0002-8742-3676
is owl:sameAs of	John R Perfect
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64932411
is author of	The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact When primary antifungal therapy fails Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations Immune reconstitution syndrome associated with opportunistic mycoses Plasminogen alleles influence susceptibility to invasive aspergillosis Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis Correction: Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex Analysis of the genome and transcriptome of Cryptococcus neoformans var. grubii reveals complex RNA expression and microevolution leading to virulence attenuation Role of Alternative Oxidase Gene in Pathogenesis of Cryptococcus neoformans Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial Phylogenomic analysis of non-ribosomal peptide synthetases in the genus Aspergillus. Cryptococcosis diagnosis and treatment: What do we know now Immune reconstitution syndrome and exacerbation of infections after pregnancy Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Brain inositol is a novel stimulator for promoting Cryptococcus penetration of the blood-brain barrier Host defenses against cryptococcosis Cryptococcosis Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis Combination antifungal therapy Liposomal amphotericin B: clinical experience and perspectives Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software